We have investigated the effect of a series of bisphosphonates derived from
fatty acids against Trypanosoma cruzi proliferation in in vitro assays. So
me of these drugs proved to be potent inhibitors against the intracellular
form of the parasite exhibiting IC50 values at the low micromolar level. As
bisphosphonates are FDA clinically approved for treatment of bone resorpti
on, their potential innocuousness makes them good candidates to control tro
pical diseases. (C) 2001 Elsevier Science Ltd. All rights reserved.